Revue internationale de recherche et développement en pharmacie et sciences de la vie

Article spécial

Biosimilars: Global Acceptance, Importance of Regulatory Consistency and current trends

• Aruna Dontabhaktuni

Article spécial

Translational Oncology Research and its Clinical impact using pioneering examples

• Motawa E. El Houseini

Article spécial

Packaging Challenge for Affordable Biosimilar Products

• Anupam  Chanda

Article spécial

Role of Women in the Study of Analgesic activity of Holarrhena antidysenterica leaves extract

• Megaravalli Krishnappa Hegde Veena

Article spécial

Biomanufacturing Programmes for Early Phase mAb Development

• Nicholas Hutchinson

Article spécial

Regulatory Progress of Biosimilars: An Update

• Alokkumar Bandyopadhyay

Article spécial

in vitro screening of cytotoxic activities of hopea ponga (dennst.) Bark extracts

• Hosadu Manjappa Vagdevi

Article spécial

In Vivo Anti-Inflammatory Activity Of Pajanelia Longifoliabark Extracts

• Parameshwarappa Latha Kotehal

Article spécial

Virtual Behavioural Health Integration into Primary Care – A Clinical Trial

• Manuel A Castro

Article spécial

Illegal Trafficking of Banned Drugs of Having Adverse Effect on Human Health.

• Amit Chauhan

Article spécial

The Connective Tissue Manipulation as Prevention to Avoid Anti-inflammatories in Musculoskeletal Pain

• Renato Vilella

Article spécial

Financial and Economic Criteria for Evaluating the Performance of Pharmacies

• Ali Imani

Article spécial

Copyright in Gene Sequences

• Mark Engelman

Article spécial

A Comprehensive and Multidisciplinary Methodology to Improve Biosimilar Uptake in the United States

• Sophia Z Humphreys

Article spécial

Comparative Study of Pharmacokinetics and Safety of RPH-001 and Avastin after Single Dose 5mg/kg Given Intravenously to Healthy Male Volunteers

• Shorena Archuadze  

Article spécial

Cage Match: Inter Partes Review and Post Grant Review vs. Biologics and Biosimilars

• Ha Kung Wong

Article spécial

Biosimilars Interchangeability in the USA: The Final US-FDA Guidance to Industry

• Michel Mikhail

Article spécial

Biosimilars Summit & Clinical Trails 2020_Past conference Report